Zhong Yuan Bio-Technology Holdings (Zhong Yuan Bio-Technology Holdings) Net Income From Continuing Operations : $-0.35 Mil (TTM As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Zhong Yuan Bio-Technology Holdings Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Zhong Yuan Bio-Technology Holdings's net income from continuing operations for the six months ended in Sep. 2023 was $0.43 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.35 Mil.

Zhong Yuan Bio-Technology Holdings Net Income From Continuing Operations Historical Data

The historical data trend for Zhong Yuan Bio-Technology Holdings's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhong Yuan Bio-Technology Holdings Net Income From Continuing Operations Chart

Zhong Yuan Bio-Technology Holdings Annual Data

Trend

Dec16

Dec17

Dec18

Mar19

Mar20

Mar21

Mar22

Mar23

Net Income From Continuing Operations

Get a 7-Day Free Trial

0.28

-0.09

-0.03

-1.13

-2.30

Zhong Yuan Bio-Technology Holdings Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Net Income From Continuing Operations	Get a 7-Day Free Trial								-0.21	-0.47	-0.97	-0.78	0.43

Zhong Yuan Bio-Technology Holdings Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.35 Mil.

Zhong Yuan Bio-Technology Holdings (Zhong Yuan Bio-Technology Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Zhong Yuan Bio-Technology Holdings Ltd (OTCPK:ZHYBF) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

N/A

Address

28 Queen’s Road East, Suite 901, Tesbury Centre, Wanchai, Hong Kong, HKG

Website

https://www.zybioholdings.com

Zhong Yuan Bio-Technology Holdings Ltd is engaged in the business of developing and marketing nervonic acid-based health supplements and sales of acer truncatum seedlings. The company has two reportable segments such as sales of health care supplements and technical supporting services. The company generates its revenue primarily from the sales of health care supplements.

Executives

Tingting Chang	director, 10 percent owner, officer: CEO	RM 1002, 10THFL, LONG HU FUTURE OFFICE, NO. 1 EAST SHI LI PU ROAD, CHAO YANG DISTRICT, BEIJING F4 100024
James M Cassidy	director, 10 percent owner, officer: president,secretary,treasurer	215 APOLENA AVENUE, NEWPORT BEACH CA 92662
James K Mckillop	director, 10 percent owner, officer: Vice President	9454 WILSHIRE BOULEVARD, SUITE 612, BEVERLY HILLS CA 90212

Zhong Yuan Bio-Technology Holdings (Zhong Yuan Bio-Technology Holdings) Headlines

No Headlines